KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jan 28, 2026 - 3:59PM >>  ABB India 5046.15  [ 7.20% ]  ACC 1685.5  [ -0.18% ]  Ambuja Cements 533.9  [ 0.54% ]  Asian Paints Ltd. 2510.85  [ -4.34% ]  Axis Bank Ltd. 1320.5  [ 0.46% ]  Bajaj Auto 9459  [ -0.38% ]  Bank of Baroda 306.15  [ 1.32% ]  Bharti Airtel 1954.95  [ -0.85% ]  Bharat Heavy Ele 259.65  [ 4.74% ]  Bharat Petroleum 362.4  [ 1.41% ]  Britannia Ind. 5742  [ -2.40% ]  Cipla 1331.8  [ 1.44% ]  Coal India 444.25  [ 5.10% ]  Colgate Palm 2153.55  [ -0.14% ]  Dabur India 517.9  [ 0.68% ]  DLF Ltd. 627.05  [ 2.90% ]  Dr. Reddy's Labs 1224.3  [ -1.27% ]  GAIL (India) 168.1  [ 5.06% ]  Grasim Industries 2842.9  [ -0.48% ]  HCL Technologies 1730.4  [ 0.61% ]  HDFC Bank 932.65  [ 0.63% ]  Hero MotoCorp 5501.05  [ 2.28% ]  Hindustan Unilever 2386.9  [ -0.56% ]  Hindalco Industries 998.7  [ 3.81% ]  ICICI Bank 1367.4  [ 0.30% ]  Indian Hotels Co 656.3  [ 0.96% ]  IndusInd Bank 898  [ 0.36% ]  Infosys L 1666.4  [ -1.01% ]  ITC Ltd. 321.25  [ 0.77% ]  Jindal Steel 1119.05  [ 3.52% ]  Kotak Mahindra Bank 412.65  [ 0.90% ]  L&T 3793.65  [ 0.10% ]  Lupin Ltd. 2132.65  [ -0.70% ]  Mahi. & Mahi 3448.65  [ 1.60% ]  Maruti Suzuki India 14876.8  [ -2.39% ]  MTNL 31.31  [ 0.97% ]  Nestle India 1292.7  [ -0.83% ]  NIIT Ltd. 75.29  [ 3.89% ]  NMDC Ltd. 81.51  [ 3.44% ]  NTPC 348.2  [ 0.88% ]  ONGC 268.65  [ 8.30% ]  Punj. NationlBak 124.5  [ 1.30% ]  Power Grid Corpo 259.75  [ 2.10% ]  Reliance Inds. 1397.05  [ 1.16% ]  SBI 1062.8  [ 0.94% ]  Vedanta 737.1  [ 4.46% ]  Shipping Corpn. 220.55  [ 4.50% ]  Sun Pharma. 1610.15  [ -1.78% ]  Tata Chemicals 729  [ 2.63% ]  Tata Consumer Produc 1132.05  [ -4.71% ]  Tata Motors Passenge 340.45  [ -0.03% ]  Tata Steel 193.8  [ 0.68% ]  Tata Power Co. 355.05  [ 2.01% ]  Tata Consultancy 3199.85  [ 1.31% ]  Tech Mahindra 1762.45  [ 0.99% ]  UltraTech Cement 12773.1  [ 1.44% ]  United Spirits 1330  [ 1.36% ]  Wipro 237.4  [ 1.02% ]  Zee Entertainment En 83.97  [ 5.97% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

GUJARAT THEMIS BIOSYN LTD.

28 January 2026 | 03:45

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE942C01045 BSE Code / NSE Code 506879 / GUJTHEM Book Value (Rs.) 24.27 Face Value 1.00
Bookclosure 05/09/2025 52Week High 479 EPS 4.48 P/E 69.57
Market Cap. 3393.18 Cr. 52Week Low 208 P/BV / Div Yield (%) 12.83 / 0.22 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by producing antibiotic erythromycin, and erythromycin salts and formulations. GTBL was a sick company which was forced to discontinue production because of accumulated losses. The company was takenover during June 1991 by pharmaceutical Business Group India Ltd; a unique consortium of five competing drug companies - Themis Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company has technical and financial collaboration with Yuhan Corporation, South Korea. With Yuhan's knowhow, GTBL has become India's first company to start commercial production of anti-tubercolis drug, rifampicin. 2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand has been appointed as the Managing Director of the Company w e f February 01, 2002. 2008 -Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional Director of the Company. -The Company has appointed Mr. Rajneesh Anand as Managing Director 2010 - Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as Additional Director of the Company. 2011 -The Board of Directors appointed Mr. Rajneesh Anand as Managing Director of the Company 2012 -The Company has received a Rehabilitation Scheme approved by the Board of Industrial and Financial Reconstruction (BIFR) 2014 -Mr. Vikas Tarekar has been appointed as a Company Secretary of the company. -Mr. Tapas Guha has been appointed as a CEO of the Company. 2023 -The Company has splits its face value from Rs. 5/- to Rs. 1/-. 

2024 
-The Company has issued Bonus Shares in the Ratio of 1:2.
-The Company has approved the Scheme of Amalgamation of Gujarat Themis Biosyn Ltd. with Themis Medicare Ltd.
      
2025
-The Company has listed his 10,89,65,265 equity shares of face value of Rs.1/- each, fully paid up in National Stock Exchange (NSE)